Management of vitiligo.
Shaffrali
F
F
Department of Dermatology, Royal Hallamshire Hospital, Sheffield, UK.
Gawkrodger
D
D
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002374:Catalase / Q000627:therapeutic use; D003358:Cosmetics / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D010778:Photochemotherapy / Q000379:methods; D013473:Sunscreening Agents / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use; D014820:Vitiligo / Q000175:diagnosis / Q000523:psychology / Q000628:therapy
D000893:Anti-Inflammatory Agents; D003358:Cosmetics; D005938:Glucocorticoids; D006873:Hydroquinones; D013473:Sunscreening Agents; D014807:Vitamin D; C038109:pseudocatalase; D002374:Catalase